ProQR Therapeutics N.V. Share Price
NASDAQ: PRQRProQR Therapeutics N.V. Stock Performance
ProQR Therapeutics N.V. Share Price Today
As of 30 October 2026, ProQR Therapeutics N.V.'s share price is $1.44. The stock opened at $1.43, compared to its previous close of $1.41. During today's trading session, ProQR Therapeutics N.V.'s share price traded between $1.41 and $1.50, with an average price of $1.45. Over the past 52 weeks, the stock has recorded a high of $2.80 and a low of $1.21. In terms of performance, ProQR Therapeutics N.V.'s share price has declined by 8.60% over the last six months and is down 47.53% on a year-on-year basis.
ProQR Therapeutics N.V. Share Price Chart
ProQR Therapeutics N.V. Annual Profit & Loss
All figures in USD
About ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics. Geographically, the company operates in United States.
ProQR Therapeutics N.V. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $1.66 | $1.43 | -14.67% |
Sep 2026 | $2.12 | $1.67 | -28.02% |
Aug 2026 | $1.69 | $2.32 | +34.10% |
Jul 2026 | $1.93 | $1.73 | -7.24% |
Jun 2026 | $1.52 | $1.86 | +17.30% |
May 2026 | $1.55 | $1.59 | +1.27% |
Apr 2026 | $1.65 | $1.57 | -3.38% |
Mar 2026 | $1.57 | $1.63 | +2.20% |
Feb 2026 | $1.61 | $1.59 | -1.85% |
Jan 2026 | $2.05 | $1.62 | -19.36% |
Dec 2025 | $2.28 | $2.01 | -14.15% |
Nov 2025 | $2.80 | $2.34 | -14.44% |